Physician

Akbar H Obaray, MD

According to 2025 Medicare claims, Akbar Obaray, MD (NPI: 1104863299) practices pulmonary disease in the Trenton-Princeton, NJ market, with the plurality of this provider's patient population coming from Mercer, NJ. This provider's primary affiliated billing organization is PULMONARY AND SLEEP ASSOCIATES OF MERCER-BUCKS (NPI: 1023853579; TIN: 993720553) and primary practice location at 08690-3403. Obaray is affiliated with the Capital Health Accountable Care Organization, LLC (ACO ID: A2528), participating under the MSSP model.

Obaray's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 130 traditional Medicare patients, billed 230 HCPCS/CPT codes, and received $20,789 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,837 prescription claims across 266 beneficiaries totaling $636,461 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 851 claims. Open Payments data shows 5 records totaling $217. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $202,435 to $20,789. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, reported payments moved up and down with repeated peaks and valleys, starting at $95,762 and ending at $52,477.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	655	3,469	$202,435
2016	603	3,287	$195,813
2017	459	2,582	$153,711
2018	405	2,328	$153,359
2019	342	1,830	$122,881
2020	262	1,125	$68,188
2021	292	1,354	$99,836
2022	306	982	$74,665
2023	221	544	$48,393
2024	130	230	$20,789

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	367	3,853	$533,587
2016	349	3,527	$477,016
2017	335	3,492	$534,680
2018	334	3,374	$904,924
2019	308	3,098	$883,125
2020	284	2,933	$799,112
2021	357	3,195	$839,552
2022	341	2,976	$702,073
2023	337	3,105	$1,035,477
2024	266	1,837	$636,461

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	530	1,812	$100,732
2016	616	2,027	$77,150
2017	580	1,690	$50,091
2018	490	1,624	$50,399
2019	532	1,585	$44,716
2020	483	1,765	$66,551
2021	468	1,585	$68,377
2022	448	1,445	$74,606
2023	398	1,369	$87,218
2024	293	851	$51,958

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	93	153	$102
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	54	64	$59

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	118	4,800	$100,054
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	56	2,742	$56,380
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	66	3,600	$51,479
Dupixent Pen	Dupilumab	13	351	$47,642
Breo Ellipta	Fluticasone/Vilanterol	41	1,920	$24,208

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	23	$23,109
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	14	116	$7,736
A7030	Full face mask used with positive airway pressure device, each	N	20	44	$3,457
E0601	Continuous positive airway pressure (cpap) device	Y	16	102	$2,838
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	27	54	$2,431

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	5	$217	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Akbar H. Obaray, MD?

Tedicare shows public-source Medicare data for Akbar H. Obaray, MD (NPI 1104863299), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Akbar H. Obaray, MD have ACO affiliation data?

Akbar H. Obaray, MD is shown with ACO affiliation data for Capital Health Accountable Care Organization, LLC (MSSP, ACO ID A2528).

What billing organization is linked to Akbar H. Obaray, MD?

Akbar H. Obaray, MD is linked to PULMONARY AND SLEEP ASSOCIATES OF MERCER-BUCKS (billing NPI 1023853579) in the available physician profile data.

Does Akbar H. Obaray, MD have Open Payments data?

Akbar H. Obaray, MD has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.